# Novo Nordisk Inc. – FDA Inspection, Feb 7, 2025

Source: https://www.keypedia.com/records/fda_inspections/novo-nordisk-inc/b68c3a3c-5d39-4d5e-b050-802a21bd26f0
Source feed: FDA_Inspections

> FDA inspection 1255957 of Novo Nordisk Inc., February 07, 2025. Classification: Official Action Indicated (OAI). 4 citations under 21 CFR part 314. 10 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1255957
- Company Name: Novo Nordisk Inc.
- Inspection Date: 2025-02-07
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Citation Count: 4

## Related Documents

- FDA Inspection 1194065 - 2022-12-21
- FDA Inspection 1018484 - 2017-06-08
- [FDA Inspection 1013344 - 2017-04-13](https://www.keypedia.com/records/fda_inspections/novo-nordisk-inc/1d5c8257-f349-440a-9ebf-72db3b05a4f4)
- FDA Inspection 983531 - 2016-07-22
- FDA Inspection 968597 - 2016-04-12

## Related Officers

- [Investigator](https://www.keypedia.com/people/mayar-m-mussa/4f39b1c8-93a6-4bc9-a800-5f802db48be6)
- [Company Rep](https://www.keypedia.com/people/tyanna-n-hadley/8fdebfd7-d6f3-44ab-9dcb-864ab6d55d53)

Company: https://www.keypedia.com/companies/novo-nordisk-inc/920bb4ea-9450-45a6-bcd7-9f85c2f2bbad
